News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Eisai Inc. Divests Clinical Diagnostics Supply Biz for $183 Million
November 30, 2015
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Eisai will sell its clinical diagnostics business – EIDIA Co. Ltd - to Sekisui Chemical for JPY 22.4bn ($183m).
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Asia
Eisai Inc.
MORE ON THIS TOPIC
Breast cancer
Novartis Buys Breast Cancer Drug for $2B to Keep Up With Myriad Rivals
March 20, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
AstraZeneca Building Shanghai Production Plant to Support Cell Therapy Strategy
March 19, 2026
·
2 min read
·
Nick Paul Taylor
Mergers & acquisitions
Revolution, Ascendis Named Top Buyout Targets as Industry Awaits The Big One
March 19, 2026
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
In Tight Deal Environment, Pharma May Need To Think Big
March 18, 2026
·
5 min read
·
Annalee Armstrong
